Colorado’s Prescription Drug Affordability Board (PDAB) has issued recommendations to the state legislature aimed at enhancing consumer involvement, adjusting eligibility…
On July 9, 2024, the House of Representatives Committee on Appropriations released its Fiscal Year 2025 draft report, which includes…
On July 22, 2024, the Maryland Prescription Drug Affordability Board (PDAB) met to discuss the upcoming timeline for the next…
On July 24, 2024, the Oregon Prescription Drug Affordability Board (PDAB) held seven panels related to upper payment limits (UPLs),…
A new White Paper titled “Pharmacy Benefit Alternative Funding Programs: Key Considerations for Self-Funded Plan Sponsors” details how the saving…
On July 9, 2024, the Federal Trade Commission (FTC) released an interim report highlighting the significant impact of pharmacy benefit…
On July 2, 2024, Aimed Alliance submitted a comment to the Centers for Medicare & Medicaid Services (CMS) regarding the…
On June 26, 2024, the Oregon Prescription Drug Affordability Board (PDAB) voted to pause all ongoing drug reviews for the…
A new analysis found that the Inflation Reduction Act (IRA) could raise out-of-pocket costs for 3.5 million Medicare Part D…
On June 14, the Colorado Prescription Drug Affordability Board (PDAB) voted that a prescription drug used to treat various forms…